DESIG AD EVALUATIO OF HPMC AD XATHA GUMBASED SUSTAIED RELEASE MATRIX TABLETS OF THEOPHYLLIE

Summary In the present investigation, an attempt has been made to increase therapeutic efficacy, reduce frequency of administration, and improve patient compliance, by developing sustained release matrix tablets of theophylline. Hence, in the present work, an attempt has been made to develop sustained release matrix tablets using polymer such as hydroxyl propyl methyl cellulose (HPMC) and xanthan gum. The tablets were prepared by direct compression method. Tablets blends were evaluated for loose bulk density, tapped bulk density, compressibility index and angle of repose, shows satisfactory results. The compressed tablets were then evaluated for various physical tests like diameter, thickness, uniformity of weight, hardness, friability, and drug content. The results of all these tests were found to be satisfactory. The in vitro dissolution study was carried out for 12 hours using paddle method in phosphate buffer (pH 6.8) as dissolution media. Formulation F1 and F2 failed to sustain release beyond 8 hours. Among all the formulation, F3 shows 98.12% of drug release at the end of 12 hours. This finding reveals that above a particular concentration of HPMC K�100 and xanthan gum are capable of providing sustained drug release.

[1]  P. Mura,et al.  Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets. , 2005, Farmaco.

[2]  R. Manavalan,et al.  Controlled Release HPMC Matrix Tablets Of Propranolol Hydrochloride , 2004 .

[3]  Md. Selim Reza,et al.  Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery. , 2003, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[4]  R. Pauwels,et al.  Theophylline in the management of asthma: time for reappraisal? , 1994, The European respiratory journal.

[5]  A. Elias-Jones,et al.  Sustained release theophylline in nocturnal asthma. , 1984, Archives of disease in childhood.

[6]  S. V. Kulkarni,et al.  Design and Evaluation of Guar Gum Based Controlled Release Matrix Tablets of Zidovudine , 2010 .

[7]  R. Manavalan,et al.  Formulation And Release Characteristics Of Sustained Release Diltiazem Hydrochloride Tablet , 2003 .

[8]  Md. Selim Reza,et al.  Development of theophylline sustained release dosage form based on Kollidon SR. , 2002, Pakistan journal of pharmaceutical sciences.

[9]  A. Filiz,et al.  Addition of Salmeterol or Theophylline to an Inhaled Corticosteroid Regimen in Patients With Severe Asthma , 2002 .

[10]  B. Nath,et al.  Formulation And Evaluation Of Sustained Release Dosage Form Of Theophlline Using A Combined Hydrophobic And Hydrophilic Matrix , 2000 .

[11]  G. El-Sayed,et al.  Preparation and Evaluation of Theophylline Sustained-Release Tablets , 1996 .

[12]  N. M. Sanghavi,et al.  Sustained Release Tablets of Theophylline , 1990 .

[13]  T. Rall Drugs used in the treatment of asthma , 1990 .